Annals of
Burns and Fire Disasters - vol. XIII - n. 4 - December 2000
IMPACT OF SELECTIVE GASTROINTESTINAL DECONTAMINATION ON
MORTALITY AND MORBIDITY IN SEVERELY BURNED PATIENTS
Abdel-Razek S.M., Abdel-Khalek
A.H., Allam A.M., Shalaby H., Mandoor S., Higazi M.
Plastic, Reconstructive and Burns Unit, Tanta Faculty of Medicine, Tanta,
Egypt
SUMMARY.
Major advances have been made in the treatment of severely burned patients and
improved survival rates are being reported from many burn centres. This study considers
300 patients with a total burned body surface area of 25%0 or more in adults and 15% or
more in children. The patients were randomly allocated to three groups: group 1 (control
group) comprised 85 patients; group II (treated with selective gastrointestinal
decontamination [SLID]) 112 patients; and group III (treated with SGID + alluprinol). The
patient mortality rates were 19.0% in group 1, 5.4% in group fI, and 2.9% in group III.
There was reduction in the period of hospital stay in group II and group III patients.
SGID played a key role in the improvement of the survival rate and the reduction of
hospital stay of severely burned patients.
Introduction
The marked improvements in survival
rates after massive burns that are being reported from many centres have been attributed
to a new modality of dealing with burned patients and their wounds.' The concept of the
gut as a motor of multiple organ failure in severely burned patients has only recently
come to be considered.
Most investigations into the pathophysiology of gutderived sepsis involve the use of
animal models; however, some findings are already being corroborated - within certain
limits - in human studies. It has been reported that bacterial translocation is a
physiological phenomenon in non-compromised animals but that in compromised animals
translocation occurs more frequently and the number of translocating organisms is higher.
Patents and methods
This study considered 300
patients, after the exclusion of the patients who died within 48 h post-burn
(resuscitation period), who were admitted to Tanta University Hospital Burns Centre over a
three-year period (March 1997 to March 2000). The patients presented a burned total body
surface area (TBSA) of 25% or more in adults and 15% or more in children.
The patients were subjected to the following procedures:
- Clinical evaluation
- Resuscitation
- Oral nutritional support as soon as intestinal sounds were
audible
- Local wound care
- Systemic antibiotics if indicated, depending on culture and
sensitivity tests
- Bacteriological surveillance twice weekly
All burned patients admitted were randomly
allocated to one of three groups:
Group I (control group). This group comprised 85 patients with variable degrees
of burn. These patients were treated with local wound care only and systemic broadspectrum
antibiotics on the basis of the results of blood or wound bacterial surveillance.
Group II. This group included 112 patients treated (in addition to the control
group treatment protocol) with:
- Colistin sulphate at a rate of 150,000 units/kg/day in four
divided doses;
- Co-trimoxazole in the form of 80 mg trimethoprin + 400 mg
sulphamethoxazole twice daily for adults (half dose for children);
- Nystatin oral suspension (adult dose 500,000 IU
six-hourly).
Group III. In this group of 103 patients
we added alluprinol as xanthine oxidase inhibitor at an adult dose of 100 mg three times
daily (half dose for children).
In groups II and III, prophylactic antibiotics were not given routinely but only on a
clinical or bacteriological basis.
Results
A total number of 300 patients were
included in this study. The mean age was 22.04 ± 16.36 yr, with no statistical difference
between the three groups. The youngest patient was 9 months old and the oldest 75 years
old.
The mean TBSA was 35 ± 18.28% (Table I).
|
Group
I |
Group
II |
Group
III |
Number |
85 |
112 |
103 |
Mean ± SD |
35.30
18.28 |
35.62
17.12 |
34.85
17.20 |
F=0.05 1)
>0.05 |
|
Table I
- Comparison of the three groups with reference to percentage TBSA |
|
The mean full-thickness
burn area was 21 ± 17.46% (Table II).
|
Group
1 |
Group
II |
Group
III |
Mean ± SD |
21.12%
17.12 |
20.72%
17.20 |
17.32%
17.32 |
F
= 0.02 p>0.05 |
|
Table II - Mean
full burn in the three groups of patients |
|
The mortality rate in group
I was 19%, in group 115.4%, and in group III 2.9%0 (Table Ill).
Group |
I |
II |
III |
I#II |
I#III |
II#III |
No./9c |
85/100% |
112/100% |
103/100% |
|
|
|
Survival
Deaths |
69/81%
16/19% |
106/94.6%
6/5.4% |
100/97.1%
3/2.99 |
* |
* |
|
*
Significant |
|
Table III - Distribution of
the groups on the basis of outcome |
|
There was a statistically
significant difference between the control group and other two groups. In the control
group, mortality was 100% in children with TBSA equal to or more than 60%, while the rate
was only 33.3% if selective gastrointestinal decontamination (SGID) was applied (Table
IV).
Age (yr) |
TBSA % |
Group
I
B D |
Group
II
B D |
Group III
B D |
Birth |
15% |
22
1 |
20
0 |
22
0 |
|
25% |
6
1 |
7
0 |
7
0 |
|
45 % |
3
1 |
2
0 |
4
0 |
|
60% |
1
l |
3
1 |
1
1 |
12 |
15% |
0
0 |
0
0 |
0
0 |
|
25% |
39
1 |
52
0 |
47
0 |
|
45
%0 |
2
2 |
10
I |
6
0 |
|
60% |
6
6 |
13
3 |
10
1 |
> 60 |
15% |
0
0 |
0
0 |
0
0 |
|
25% |
1
0 |
1
0 |
2
0 |
|
45% |
1
1 |
1
1 |
0
0 |
|
60% |
4
2 |
3
0 |
4
1 |
|
Total |
85
16 |
112
6 |
103
3 |
B = Burned D = Deceased |
|
Table IV -
Mortality in patients with TBSA over 15%o distributed in relation to age and percentage
TBSA |
|
The period of
hospitalization was longer in the control group, with a mean of 30.1 ± 9.7 days, compared
with 23.9 ± 9.4 days in the SGID group, with a significant statistical difference
between the control group and other two groups (Table V).
|
Group
I |
Group
II |
Group
III |
|
No.
= 85 |
No.
= 112 |
No.
103 |
Mean days
±SD |
30.11
9.7 |
23.86
9.42 |
24.9
9.6 |
F=120.08
p<0.001 |
|
Table V -
Comparison between groups with reference to duration of hospitalization |
|
Discussion
This study reports on survival and the
length of hospital stay in relation to burn size, age, and SGID in 300 consecutive
patients treated in the last three years in the Tanta Burns Unit. The mortality rate in
the control group was 19%, compared with 5.4% in patients receiving SGID; when
alluprinol was also administered to SGID patients, mortality fell to 2.9% (statistically
significant).
Major advances have been made in the treatment of severely burned patients, and improved
survival rates are being reported from a number of burns centres.
Between 1983 and 1989, the overall mortality rate in the USA was between 6 and 20%,
compared with 20% in the UK.' These figures vary considerably, some being quite high, e.g.
a centre in Alexandria reported 21 %,° while Fadaak et al.' reported a mortality of 6.9%.
Chen et al.' studied the effect of early escharectomy on intestinal microflora.
Monafo et al.' attributed improved survival to the use of topical silver sulphadiazine
while Herek et al."' studied the effects of immunotherapy on bacterial Tanslocation
in burn wound infection.
Demling" attributed the improved survival in massive burns to better methods of burn
management. Although Gram-negative enteric bacteria are frequently isolated from the burn
wound, little attention has been paid to the patient's gastrointestinal tract, while the
relationship between the microflora of the digestive tract and the microflora of the burn
wound has repeatedly been reported.
The translocation of enteric bacilli, endotoxin, and yeast after major burns has been well
demonstrated in experimental models.' In our study we investigated the impact of SGID on
mortality and the length of hospital stay in cases of severe burn injury.
Mackie et al." investigated the use of SGID in patients with extensive burns, but the
study included only a limited number of cases (33 patients). In the present study,
children in the SGID group presented no mortalities when the TBSA was less than 60%, which
is consistent with Feller's sigmoid curve. Saffle" reported an overall survival rate
of 80%o and 67% in patients aged over 75 yr.In Shanghai, Li et al." reported a
mortality rate of 32.7Q in burn patients aged o% er 65 yr. -Mason et a1. reported that
there was significantly increased mortality in patients with Gram-negative bacteraemia
also in patients with a positive blood culture for yeast but no increase attributed to
Gram-positive bacteraernia.
In our study we did not record any mortalitx in nonshocked non-bacteraemic patients. while
mortality was 9.1c% in the control group. When the patients were shocked but not
bacteraemic the mortality rate was 500~ in the control group: the rate was -1.8c'c in the
SLID group. and there was no mortality in the SGID group when alluprinol was added to the
SGID regimen.
On admission. if the patients were shocked and bacteraemic. the mortality rate ryas
60.7Cé in the control group, while with SGID it "as 35.717c; when admission shock
was associated with enteric bacteraemia the mortality rate "as markedly increased to
73.7~ in the control group, while it was 50c,'c in the SGID group. and the rate was
-1?.9c-c if alluprinol was added to the SGID regimen.
In our study the mean hospital stay was 30.11 ± 9.70 days in the control group, compared
with 23.86 ± 9.-1? days in the SGID group: this represents a beneficial reduction in
financial cost. Itlanson et al.'° in 1987 reported that the mean hospitalization period
was 35 days in the SGID group. and in 1992 1flanson" again attributedJthe length of
hospital stay to the extent of the burned area. the age of the patient, and also to
colonization with enteric bacteria.
Our study indicated that SGID played a key role in the improvement of the survival rate
and in the reduction of hospital stay in severely burned patients.
RESUME. Des progrès très
importants ont été réalisés dans le traitement des Brands br6lés et beaucoup de
centres des br6lds communiquent des taut de survie améliords. Les Auteurs présentent
dans cette etude leurs rdsultats avec 300 patients atteints de brîllures de ?Scc ou de
plus de la surface corporelle chez leg adultes et IScc ou de plus chez leg enfants.
Les patients ont ere divisés au hasard en trois grouper: le groupe I (Qroupe témoinl
contenait 85 patients: le groupe II 1 aroupe de decontamination gastrointestinale
selective [sigle anglais: SGID] 112 patients: et le groupe III 1 SGID + alluprinol 1. Les
taut de mortalite des patients étaient 19.0% dans le aroupe I. 5.5c--c dans le groupe II
et 22,9cc dans le groupe III. Les Auteurs ont observe une reduction dans la periode de
Fhospitalisation dans leg patients des grouper II et III. La SLID a jour un r61e
fondamental dans Famélioration du taux de la survie et dans la rdduction de
-'hospitalisation des patients sevèrement br6ld
BIBLIOGRAPHY
Shalaby H.. Higazi M., El Far N.: Selective
gastrointestinal decontamination and burn wound sepsis. Ann. Burns and Fire Disasters. 11:
?3. 1998.
Papini R.P.G., Wilson A.P.R.. Steer J.A.: Wound management
in burn centres in the United Kingdom. Br. J. S.. 83:505. 1995.
Wells C.I., Jechorek R. P.. Madclaus hI.A.: Effects of
clindamycin and metronidazole on the intestinal colonization and translocation of
enterococci in mice. Antimicrob. Agents Chemother., 32: 1765, 1998.
Heimbach D.M.: The results of early primary excision. J.
Trauma. 21:732-4, 1981.
Pruitt B.A.. Jr., \lc-Manus A.T.: The changing epidemiolog~
of infection in burn patients. World J. Surg., 16: 5 7. 1992.
Nlostafa M.F.. Burhan A.. Abdalla A.F. et al.: A
retrospectiN-e study of 5505 burned patients admitted to Alexandria Burn Unit. Ann.
Nledit. Bums Club. 3: _'69, 1990.
Fadaak H.. Al-Kurashi \., Mahaluxmivala S. et al.: Burn
injury admissions to a ne~ burns unit in Buraidah. Qassim. Saudia Arabia - a study of 318
cases. Ann. Nledit. Burns Club. 8: 4. 1995.
Jun Chen. Taping Zhang. Guangxia Xiao: Clinical
investigation of changes in intestinal microflora in burn patients after early
escharectomy en masse. Ann. Burns and Fire Disasters, 13: 10-13. 2000.
Nlonafo " AV., Robinson H.\.. Tashioka T. et al.:
Lethal bums. A progress report. Arch. Surg.. 113: 397-401. 1978.
Herek O., Ozt6rk H.. Ozyurt NL. Atbav A. Cetinkursun S.:
Effect of treatment with immunoelobulin on bacterial transloeation in burn,wound
infection. Ann. Burns and Fire Disasters, 13: 14-17. 2000.
Demling R.H.: Improved survival after massive burns. J.
Trauma., 23: 179-8-1. 1983.
Manson W.L.. Dijkema H.. Klasen H.J.: Prevention of wound colonisation of mice
receic-ing thermal injury-. Burns. 16: 1 16. 1990.
Deitch E.A.. XU D.. Qi L. et al.: Bacterial translocation
from the gut impairs systemic immunity. Sureerv. 109: _'69. 1991.
hackie D.P.. Van Hertum W.AJ.. Sehunburg T. et al.:
Prevention of infection in burns: Preliminary experience with ;elective decontamination of
the digestive tract in patients with extensive injuries. J. Trauma, 321: 5 7 0. 199-1.
Saffle J.R.. Larson CA'L. Sullivan J.. Snelby J.: The
continuing challenge of burn care in the elderly. Surgery. 108:53-1-.t3, 1990.
Li B.-G.. Hsu " .S.. Shirr T.S.: Causes of death in
aged burn patients: Analcsis of 36 cases. Burns. 16: 207-10, 1990
Nlason A.D..'McManus A.T.. Pruitt B.A.: Association of burn
mortality and bacteraemia. Arch. Surg.. 1=1: 10_'7. 1986.
Manson W.L., `i esterveld A.W., Klasen H.J. et al.:
Selective intestinal decontamination of the digestive tract for infection prophy lasts in
severely burned patients. Scand. J. Reconst. Sure.. ?1: -169, 1987.
Manson W.L.. Klasen H.J.. Saner E.`\ . et al.: Selective
intestinal decontamination for prevention of wound colonization in severely burned
patients: A retrospecti\ a analysis. Burns. 18: 98. 1992.
This paper vsas received
on 3 June 2000.
Address correspondence to:
Dr S.M. Abdel-Razek. Plastìc. Reconshwetice
and Burn Cnit,
Tanta Faculty of Medicine. Tanta. Egypt. |
|